Improving HIV treatment and research capacity in Botswana
Developing Botswana Laboratory Capacity in HIV Genomics and HIV Cure
['FUNDING_OTHER'] · BOTSWANA-HARVARD AIDS INSTITUTE · NIH-11064049
This study is all about improving how we understand and treat HIV in Botswana, especially for young people, by training local experts and using new technology to learn more about the virus's genetics.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | BOTSWANA-HARVARD AIDS INSTITUTE (nih funded) |
| Locations | 1 site (GABORONE, BOTSWANA) |
| Trial ID | NIH-11064049 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing laboratory capabilities in Botswana to better understand and treat HIV. It aims to provide advanced training in HIV genomics and improve access to cutting-edge technologies for analyzing the virus. By leveraging local expertise and international collaboration, the project seeks to develop innovative strategies for HIV prevention and treatment, particularly for adolescents and young people. The research will also involve studying the genetic makeup of HIV in Botswana to inform future therapeutic approaches.
Who could benefit from this research
Good fit: Ideal candidates for this research include adolescents and young adults living with HIV in Botswana, particularly those who have received early treatment.
Not a fit: Patients who are not living with HIV or those outside the age range of adolescents and young adults may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for individuals living with HIV in Botswana.
How similar studies have performed: Previous research has shown success in enhancing HIV treatment outcomes through improved laboratory capabilities and genomics, making this approach promising.
Where this research is happening
GABORONE, BOTSWANA
- BOTSWANA-HARVARD AIDS INSTITUTE — GABORONE, BOTSWANA (ACTIVE)
Researchers
- Principal investigator: GASEITSIWE, SIMANI — BOTSWANA-HARVARD AIDS INSTITUTE
- Study coordinator: GASEITSIWE, SIMANI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus